Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials

(2012) Thierry Gorlia et al.   EUROPEAN JOURNAL OF CANCER

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

(2012) Roger Stupp et al.   EUROPEAN JOURNAL OF CANCER

Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysis

(2012) Teneille E. Gofton et al.   JOURNAL OF NEURO-ONCOLOGY

Investigation of cognitive impairments in people with brain tumors

(2012) Anna Rita Giovagnoli   JOURNAL OF NEURO-ONCOLOGY

Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006

(2012) K. R. Yabroff et al.   NEURO-ONCOLOGY

Systematic review of supportive care needs in patients with primary malignant brain tumors

(2012) E. Ford et al.   NEURO-ONCOLOGY

Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma

(2011) A.A. Brandes et al.   EUROPEAN JOURNAL OF CANCER

Signal transduction inhibitors and antiangiogenic therapies for malignant glioma

(2011) Ingo K. Mellinghoff et al.   GLIA

Predictors of Neuropsychological Improvement Following Cognitive Rehabilitation in Patients with Gliomas

(2011) Karin Gehring et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY

Molecular targeting of glioblastoma: Drug discovery and therapies

(2011) Ren-Yuan Bai et al.   TRENDS IN MOLECULAR MEDICINE

Molecular diagnostics of gliomas: the clinical perspective

(2010) Ghazaleh Tabatabai et al.   ACTA NEUROPATHOLOGICA

Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres

(2010) D. Sciuscio et al.   CLINICAL CANCER RESEARCH

Carboplatin Chemotherapy in Patients with Recurrent High-grade Glioma

(2010) L.J. Murray et al.   CLINICAL ONCOLOGY

Interventions for cognitive deficits in patients with a brain tumor: an update

(2010) Karin Gehring et al.   Expert Review of Anticancer Therapy

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

(2010) James R. Perry et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma

(2010) Tobias Walbert et al.   JOURNAL OF NEURO-ONCOLOGY

MGMT promoter methylation in malignant gliomas

(2010) Markus J. Riemenschneider et al.   Targeted Oncology

Extended-schedule dose-dense temozolomide in refractory gliomas

(2009) A. Berrocal et al.   JOURNAL OF NEURO-ONCOLOGY

Rechallenge with temozolomide in patients with recurrent gliomas

(2009) Antje Wick et al.   JOURNAL OF NEUROLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

(2009) Michael Weller et al.   Nature Reviews Neurology

FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme

(2009) M. H. Cohen et al.   ONCOLOGIST